Sponsored Links
South Africa's Aspen Pharmacare values GSK deal at 700 million pounds
JOHANNESBURG |
JOHANNESBURG (Reuters) - South Africa's Aspen Pharmacare Holdings (APNJ.J) on Wednesday valued its bid for two of GlaxoSmithKline's (GSK.L) thrombosis drugs and a French factory at around 700 million pounds sterling, 100 million pounds of which will be for inventory.
The proposed deal was announced last month, although neither company gave a value.
(Reporting by Helen Nyambura-Mwaura; editing by David Dolan)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints


Follow Reuters